✦ LIBER ✦

Mechanisms of enhancement of the antitumour activity of melphalan by the tumour-blood-flow inhibitor 5,6-dimethylxanthenone-4-acetic acid

✍ Scribed by Frederik B. Pruijn; M. van Daalen; Nicholas H. G. Holford; W. R. Wilson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Marked potentiation of the antitumour ac

✍ Bronwyn G. Siim; Alan E. Lee; Sahar Shalal-Zwain; Frederik B. Pruijn; Mark J. Mc 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 343 KB

Modulation of the pharmacokinetics of th

✍ Philip Kestell; Liangli Zhao; Bruce C. Baguley; Brian D. Palmer; George Muller; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 141 KB

Plasma pharmacokinetics of the antitumou

✍ Mark J. McKeage; Philip Kestell; William A. Denny; Bruce C. Baguley 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 519 KB

Modulation of thalidomide pharmacokineti

✍ Francisco Chung; Liang-ChuanS. Wang; Philip Kestell; BruceC. Baguley; Lai-Ming C 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 267 KB

Plasma disposition, metabolism and excre

✍ Philip Kestell; James W. Paxton; Gordon W. Rewcastle; Ingrid Dunlop; Bruce C. Ba 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 193 KB

In vitro and in vivo kinetic interaction

✍ Shufeng Zhou; James W. Paxton; Philip Kestell; Malcolm D. Tingle; Lai-Ming Ching 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 137 KB